Recurrent KRAS Codon 146 Mutations in Human Colorectal Cancer

作者: Sarah Edkins , Sarah O'Meara , Adrian Parker , Claire Stevens , Marcelo Reis

DOI: 10.4161/CBT.5.8.3251

关键词:

摘要: … mutations was investigated by analysing a series of non-small-cell lung cancers (NSCLC) … In summary, we have demonstrated that KRAS A146 mutations are recurrent in human …

参考文章(23)
Abby Conlin, Gillian Smith, Francis A Carey, C Roland Wolf, Robert JC Steele, The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma Gut. ,vol. 54, pp. 1283- 1286 ,(2005) , 10.1136/GUT.2005.066514
Ahmedin Jemal, Freddie Bray, Melissa M. Center, Jacques Ferlay, Elizabeth Ward, David Forman, Global cancer statistics CA: A Cancer Journal for Clinicians. ,vol. 61, pp. 69- 90 ,(1999) , 10.3322/CAAC.20107
Graham R. Bignell, Michael R. Stratton, Wendy W. Tsui, Sarah Edkins, Judy W. Ho, Siu T. Yuen, Tsun L. Chan, Philip Stephens, Helen Davies, Suet Y. Leung, Charles Cox, Richard Wooster, Annie S. Chan, P. Andrew Futreal, Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Research. ,vol. 62, pp. 6451- 6455 ,(2002)
Alberto Bardelli, D Williams Parsons, Natalie Silliman, Janine Ptak, Steve Szabo, Saurabh Saha, Sanford Markowitz, James KV Willson, Giovanni Parmigiani, Kenneth W Kinzler, Bert Vogelstein, Victor E Velculescu, Mutational analysis of the tyrosine kinome in colorectal cancers Science. ,vol. 300, pp. 949- 949 ,(2003) , 10.1126/SCIENCE.1082596
V Bazan, M Migliavacca, I Zanna, C Tubiolo, N Grassi, MA Latteri, M La Farina, I Albanese, G Dardanoni, S Salerno, RM Tomasino, R Labianca, N Gebbia, A Russo, None, Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype Annals of Oncology. ,vol. 13, pp. 1438- 1446 ,(2002) , 10.1093/ANNONC/MDF226
I. R. Vetter, The Guanine Nucleotide-Binding Switch in Three Dimensions Science. ,vol. 294, pp. 1299- 1304 ,(2001) , 10.1126/SCIENCE.1062023
J.Justin McCormick, Dajun Yang, Veronica M. Maher, Rosann A. Farber, Wilma Neuman, Ward D. Peterson, Marilyn S. Pollack, The HuT series of 'carcinogen-transformed' human fibroblast cell lines are derived from the human fibrosarcoma cell line 8387. Carcinogenesis. ,vol. 9, pp. 2073- 2079 ,(1988) , 10.1093/CARCIN/9.11.2073
Helen Davies, Graham R. Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J. Garnett, William Bottomley, Neil Davis, Ed Dicks, Rebecca Ewing, Yvonne Floyd, Kristian Gray, Sarah Hall, Rachel Hawes, Jaime Hughes, Vivian Kosmidou, Andrew Menzies, Catherine Mould, Adrian Parker, Claire Stevens, Stephen Watt, Steven Hooper, Rebecca Wilson, Hiran Jayatilake, Barry A. Gusterson, Colin Cooper, Janet Shipley, Darren Hargrave, Katherine Pritchard-Jones, Norman Maitland, Georgia Chenevix-Trench, Gregory J. Riggins, Darell D. Bigner, Giuseppe Palmieri, Antonio Cossu, Adrienne Flanagan, Andrew Nicholson, Judy W. C. Ho, Suet Y. Leung, Siu T. Yuen, Barbara L. Weber, Hilliard F. Seigler, Timothy L. Darrow, Hugh Paterson, Richard Marais, Christopher J. Marshall, Richard Wooster, Michael R. Stratton, P. Andrew Futreal, Mutations of the BRAF gene in human cancer Nature. ,vol. 417, pp. 949- 954 ,(2002) , 10.1038/NATURE00766
Astrid Lièvre, Jean-Baptiste Bachet, Delphine Le Corre, Valérie Boige, Bruno Landi, Jean-François Emile, Jean-François Côté, Gorana Tomasic, Christophe Penna, Michel Ducreux, Philippe Rougier, Frédérique Penault-Llorca, Pierre Laurent-Puig, KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer Cancer Research. ,vol. 66, pp. 3992- 3995 ,(2006) , 10.1158/0008-5472.CAN-06-0191
H J N Andreyev, A R Norman, D Cunningham, J Oates, B R Dix, B J Iacopetta, J Young, T Walsh, R Ward, N Hawkins, M Beranek, P Jandik, R Benamouzig, E Jullian, P Laurent-Puig, S Olschwang, O Muller, I Hoffmann, H M Rabes, C Zietz, C Troungos, C Valavanis, S T Yuen, J W C Ho, C T Croke, D P O’Donoghue, W Giaretti, A Rapallo, A Russo, V Bazan, M Tanaka, K Omura, T Azuma, T Ohkusa, T Fujimori, Y Ono, M Pauly, C Faber, R Glaesener, A F P M de Goeij, J W Arends, S N Andersen, T Lövig, J Breivik, G Gaudernack, O P F Clausen, P De Angelis, G I Meling, T O Rognum, R Smith, H-S Goh, A Font, R Rosell, X F Sun, H Zhang, J Benhattar, L Losi, J Q Lee, S T Wang, P A Clarke, S Bell, P Quirke, V J Bubb, J Piris, N R Cruickshank, D Morton, J C Fox, F Al-Mulla, N Lees, C N Hall, D Snary, K Wilkinson, D Dillon, J Costa, V E Pricolo, S D Finkelstein, J S Thebo, A J Senagore, S A Halter, S Wadler, S Malik, K Krtolica, N Urosevic, Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study British Journal of Cancer. ,vol. 85, pp. 692- 696 ,(2001) , 10.1054/BJOC.2001.1964